Net Cash Provided by (Used in) Operating Activities |
-15.1K |
USD |
+85.5% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
15K |
USD |
-85.5% |
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
750M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
197M |
shares |
+5.99% |
Q3 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-103 |
USD |
+88.3% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
14.4M |
USD |
+2.26% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Gross |
14.4M |
USD |
+2.21% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
14.2M |
USD |
+2.34% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
9M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
9.57M |
USD |
-8.41% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2023 |
Q3 2023 |